Infant Bacterial Therapeutics AB
STO:IBT B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Infant Bacterial Therapeutics AB
STO:IBT B
|
SE |
|
A
|
Atoss Software AG
SWB:AOF
|
DE |
|
UGE International Ltd
XTSX:UGE
|
US |
|
T
|
Times Universal Group Holdings Ltd
HKEX:2310
|
HK |
|
Goliath Film and Media Holdings
OTC:GFMH
|
US |
|
S
|
Sinco Pharmaceuticals Holdings Ltd
HKEX:6833
|
CN |
|
Japan Real Estate Investment Corp
OTC:JREIF
|
JP |
Intrinsic Value
The intrinsic value for Infant Bacterial Therapeutics AB (IBT B) under the Base Case is hidden SEK. Compared with the current market price of 49.4 SEK, the stock appears hidden .
IBT B looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether IBT B usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Infant Bacterial Therapeutics AB.
The intrinsic value for Infant Bacterial Therapeutics AB (IBT B) under the Base Case is hidden SEK.
Compared with the current market price of 49.4 SEK, the stock appears hidden .
